Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Kalvista Pharmaceuticals Inc (NQ: KALV )

10.07 -0.08 (-0.79%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Kalvista Pharmaceuticals Inc

< Previous 1 2 3 Next >
NVIDIA To Rally More Than 33%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
KALV Stock Earnings: KalVista Pharma Misses EPS for Q4 2024
KALV stock results show that KalVista Pharma missed analyst estimates for earnings per share the fourth quarter of 2024. 
Via InvestorPlace
Recap: KalVista Pharma Q3 Earnings
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Insiders Buying Dorian LPG And 2 Other Stocks
Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades. 
Via Benzinga
KalVista Pharma: Q2 Earnings Insights
Via Benzinga
Recap: KalVista Pharma Q4 Earnings
Via Benzinga
Citigroup To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
What's Going With Hereditary Angioedema-Focused KalVista Pharmaceuticals Stock On Tuesday?
Results from KalVista Pharmaceuticals' Phase 3 KONFIDENT trial. Sebetralstat, an oral on-demand therapy, shows efficacy for hereditary angioedema. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Insiders Buying Monro And 3 Other Stocks
Although U.S. stocks closed higher on Thursday, there were a few notable insider trades. 
Via Benzinga
$10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Thursday, there were a few notable insider trades. 
Via Benzinga
Analyst Expectations for KalVista Pharma's Future
Via Benzinga
Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Monday, there were a few notable insider trades. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
$230M Bet On Talos Energy? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Friday, there were a few notable insider trades. 
Via Benzinga
Insiders Buying KalVista Pharmaceuticals And 3 Other Stocks
Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades. 
Via Benzinga
$6.5M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed slightly higher on Friday, there were a few notable insider trades. 
Via Benzinga
Around $2.4M Bet On HighPeak Energy? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed lower on Friday, there were a few notable insider trades. 
Via Benzinga
KALV Stock Earnings: KalVista Pharma Misses EPS for Q2 2024
KALV stock results show that KalVista Pharma missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
3 Micro-Cap Stocks That Could Be Moonshots
If you are hungry for high-risk returns, then these micro-cap stocks to buy could be your winning ticket to future yields. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Gold Rises Over 1%; Elys Game Technology Shares Spike Higher
U.S. stocks traded mixed toward the end of trading, with the Dow Jones trading slightly higher on Tuesday. 
Via Benzinga
Why Shares of Chinese Companies Are Trading Higher? Here Are 55 Stocks Moving In Tuesday's Mid-Day Session
Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares jumped 147% to $0.4312. Elys Game Technology and Cloakbook DC have been granted license to open sportsbook in Washington, D.C. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Major Indexes Falter As Rocky Year Wraps Up
Stocks are struggling to build on their morning gains as investors began to waver on the possibility of a 
Via Talk Markets
Dow Rises 100 Points; Crude Oil Rises Over 1%
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 100 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.